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Viral ion channels are membrane proteins of influenza viruses that play essential roles in
the replication cycle, which enables them to be targeted by antiviral drugs. M2 of
influenza type A virus, BM2 of influenza type B virus, and CM2 from influenza type C
virus have been characterized as ion channel proteins and antiviral drug amantadine was
developed to control influenza type A virus. However, few studies have been conducted
to clarify the properties of the M2 protein (DM2) of influenza type D virus, a novel
influenza virus genus identified in 2014. To identify the ion channel activity of DM2, we
expressed DM2 in the oocytes of Xenopus laevis and measured the whole cell currents
using the two-microelectrode voltage clamp method. While CM2 exhibited ion channel
activity in the Xenopus oocyte as a control, DM2 also expressed the ion channel
capability in the independent test. In addition, according to the clamping data of the
oocytes expressing DM2, the current–voltage relationship was nonlinear, but it was a
sigmoid curve as the function of hyperpolarization. These results suggest that DM2 forms
a voltage-gated ion channel as CM2 does.
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Chapter I LITERATURE REVIEW
Influenza viruses
Influenza viruses are negative-sense, single-stranded RNA viruses belonging to the
Orthomyxoviridae family. There are five genera in Orthomyxoviridae family: Influenza
virus A, Influenza virus B, Influenza virus C, Thogovirus, and Isavirus (Alexander,
2007). Influenza viruses and Thogovirus have been established for a long time, and
Isavirus was relatively newly found. The C/OK viruses, provisionally identified as a
subtype of Influenza C virus (ICV), have been characterized as distinct from ICV (Hause,
2014). Therefore, a sixth genus named Influenza D virus will soon be created (Hause,
2014). Influenza A, B, and C cause influenza in a variety of vertebrate species, including
human, avian species, and other animals. Influenza D has only been isolated in swine and
cattle so far; however, it also has potential threaten to human health as these animals are a
potential virus reservoir. The classification of influenza viruses into separate genera is
based on two major internal proteins of influenza virus: nucleoprotein (NP) and matrix
(M) protein. Influenza A is further classified into subtypes on the basis of the nature of
their surface glycoproteins, namely, hemagglutinin (HA) and neuraminidase (NA) (Lamb
R. K., 2001). To date, 18 different Hemagglutinin (H1– H18) antigens and 11 different
neuraminidase (N1– N11) have been isolated. Each virus subtype has one hemagglutinin
and one neuraminidase, and in theory, 198 different combinations are possible.
Two different strategies, vaccination and chemotherapy, have been used to combat
influenza. H1N1 and H3N2 of influenza A as well as influenza B were selected to
produce vaccination for human use (Manzoli, 2012). However, the effectiveness of
vaccination is limited due to antigenic drifts and shifts. The M2 protein of influenza A,
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which is an ion channel membrane protein permeable to protons, is the major target of
antiviral drugs. Therefore, the anti-influenza drugs are only effective against influenza
virus A strains.
Ion channel proteins
Ion channels are membrane proteins that gate the flow of ions across the cell membrane
by forming water-filled pores (Fischer W. S., 2002). Ion channels can provide a high
conducting, hydrophilic pathway across the low dielectric, hydrophobic interior of the
phospholipid bilayers (Hille, 2001). They are distinguishable from aqueous pores on
account of their ion selectivity and gating activity. Ion channels can discriminate between
size and charge of permeant molecules and control their passage rate through the
selectivity filter. In addition, ion channels are gated, allowing them to temporarily open in
response to a specific stimulus and close again (Figure 1). The main types of stimuli
include voltage gradient across the membrane, binding of a ligand (extracellular or
intracellular ligand), and mechanical stress (Hille, 2001). The stimulation causes a
conformational change in channel protein structure, which results in the opening of the
channel gate, ultimately leading to the succeeding ion flux across the plasma membrane.
Viral ion channel proteins are short auxiliary membrane proteins with a length of 50–120
amino acids. They have been found in a number of viral genomes and play essential roles
in the virus replication cycle, such as virus entry, assembly, and release, by changing the
electrochemical or proton gradient in the subcellular compartments in host cells (Wang
K. X., 2011). One of the main reasons for the focus on ion channel proteins in influenza
viruses is that they can be ideal targets for antiviral drugs, due to their importance in the
virus life cycle (Clercq, 2006; Ohigashia, 2009). The basic principle for the inhibition of
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ion channel proteins is to either inhibit the channel activity or the assembly of the channel
itself (Wang K. X., 2011). The ion channel proteins identified in influenza A, B, and C
are designated as M2, BM2, and CM2, respectively, the functions and structures of which
will be discussed in the following sections.
M2 protein of influenza A
M2 is a single-pass, NinCout oriented membrane protein that consists of 97 amino acids
(Pinto, 1992). It is produced from the spliced mRNA transcript that shares a high
similarity with that of Matrix 1 protein. M2 is composed of an N-terminal ectodomain
(residues 1–23), a transmembrane domain (residues 24–46), and a C-terminal
cytoplasmic domain (residues 47–79). The native state of M2 is a homo-tetramer that
consists of a pair of dimers covalently linked by disulfite bonds. M2 forms a pH-gated
proton channel in the viral lipid envelope. The activation of M2 depends on the low pH
of an endosome, and the following conductance is controlled by the inter-subunit
interaction between histidine 37 and tryptophan 41. The high proton conductivity is
conferred by histidine 37, and the channel gate is conferred by tryptophan 41 (L.H. Pinto,
1997). At high pH, the tryptophan gate is locked through the interaction with Aspartic
acid 44, and the transmembrane helices are tightly packed. At low pH, the imidazole ring
of His 37 is protonated (Okada, 2001), which destabilizes the transmembrane helix
packing and breaks the interactions between Trp 41 and Asp 44, allowing the gate to flip
open (Thomaston J.L., 2015).
M2 plays an essential role in viral infection and successful replication in host cells by
modulating the pH across the membrane during the entry of virus particles and across the
trans-Golgi membrane during viral maturation (McCown, 2006). Influenza A viruses
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enter the host cell by expressing M2 protein in the plasma membrane (Schnell, 2008). As
a consequence, the host cell incorporates this section of membrane through the
endocytosis pathway with virions entrapped in the endosome and employs ATPases to
acidify this compartment. Sensing the low pH in the endosome, M2 mediates the change
of pH by conducting protons into the interior of the virion, which enables conformational
changes of the virus membrane proteins such as hemagglutinin and Matrix 1 protein
(Sakaguchi, 1997). As a result, the viral membrane fuses with the endosomal membrane,
and the viral genome is released to the host cell. In addition, during the late stage of the
infectious cycle for influenza A, M2 is responsible for maintaining a neutral pH in the
Golgi, which in turn prevents HA from adopting the low-pH structure that may cause the
assembly of nonfunctional HA in the virion (Ciampor, 1992). Based the importance of
M2 protein in the influenza virus replication cycle, this protein has been a target for
influenza drug development (Fischer W. B., 2012). In the presence of 1aminoadamantane hydrochloride, an inhibitor of M2 ion channel activity, protons fail to
enter the virion, which then cannot disintegrate from the endosome, thus blocking the
influenza A viruses from taking over the host cell (Pielak, 2009; Wang C. T., 1993).
BM2 protein of influenza B
The influenza B virus BM2 protein contains 109 amino acid residues and is translated
from a +2 nucleotides open reading frame. The initiation codon of BM2 overlaps with the
stop codon of the M1 protein, indicating that BM2 synthesis is triggered by the
termination of M1 translation (Horvath, 1990). BM2 is a type III integral membrane
protein with a NoutCin orientation and comprises a 23-residue transmembrane domain as
well as an 86-residue C-terminal cytoplasmic domain. Like M2 from influenza A, BM2

10

forms a proton channel, which is activated at acidic pH. In addition, BM2 is a
homotetramer in its native state and is involved in the virus uncoating process in the
endosome (Paterson, 2003). It is post-transcriptionally modified by phosphorylation,
incorporated into virions, and expressed on the membrane of virus-infected cells
(Odagiri, 1999). Although M2 and BM2 share no sequence similarity in the
transmembrane domain, the HXXXW motif is found in both of them. Histidine 19 and
tryptophan 23 of the BM2 protein are essential for pH sensing and channel gating, as are
the corresponding proteins, histidine 37 and tryptophan 41, of M2 protein (Otomo, 2009).
However, the activity of BM2 is completely insensitive to the anti-influenza drugs
amantadine and rimantadine (Mould, 2003 ).
CM2 protein of influenza C
CM2 is an integral membrane glycoprotein that forms homodimers and homotetramers
linked by disulfite bonds. It is generated by proteolytic cleavage of a 374-amino acid P42
protein, which is composed of a 259-amino acid N-terminal matrix protein (M1) and a
115-amino acid C-terminal CM2 protein (Hongo S. S., 1999). CM2 has a NoutCin
orientation in membranes with a 23-residue N-terminus extracellular domain, a 23residue transmembrane domain, and a 69-residue C-terminal cytoplasmic domain
(Furukawa, 2011). It is post-translationally modified by palmitoylation through a labile
thioester linkage, by N-glycosylation via addition of an N-linked oligosaccharide chain
and by phosophorylation (Hongo S. S., 1997; Li, 2001). CM2 forms a voltage-activated
ion channel that is permeable to chloride ions and perhaps protons (Hongo S. I., 2004;
Muraki Y, 2009). Unlike M2 of influenza A, CM2 is not sensitive to the antiviral drugs
amantadine and rimantadine. CM2 is expressed at the plasma membrane of virus-infected
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cells and incorporated into virions. It is crucial to the influenza C replication by playing a
role in the uncoating and packaging processes. The mechanism how the CM2 channel
activities relate to their roles remains unclear and needs further investigation.
Electrophysiological recording
Xenopus oocytes have been widely used for studying ion channel proteins in vivo because
of the unique advantages of the oocytes (Weber, 1999), such as their large size, relative
ease of handling, and low expression of endogenous channels and receptors.
Electrophysiology is considered the most sensitive approach to study ion channel
function with the use of Xenopus oocytes. Among the electrophysiological techniques,
the two-microelectrode voltage clamp (TEVC) method, which studies the properties of
electrogenic membrane proteins by artificially controlling the membrane potential, is the
most common one for electrophysiological investigation in voltage clamping large cells
(Guan, 2013). In combination with various biological approaches, the Xenopus oocyte
expression system and TEVC are employed to study the structure and function of ion
channels and receptors.
Two-electrode whole-cell voltage clamping of oocytes makes use of two intracellular
electrodes, with one of them measuring the internal potential of the oocyte as a Vm sensor
and the other injecting current to change the membrane potential to a desired value
(Figure 2). Both electrodes are interconnected through a feedback amplifier and gently
injected into the cell membrane to artificially control membrane potential (Baumgartner,
1999). The membrane potential measured by the Vm sensor is compared with a command
voltage, and the difference between them is manipulated by the amplifier to force a
current proportional to that difference to flow through the current electrode into the cell
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(Polder & Swandulla, 2001). Thus, the difference between the voltages is brought to zero,
and the cell membrane potential is clamped at a constant value. With the opening of the
ion channel, deviations from the clamped membrane potential are corrected by ions
entering through the clamp electrode. By measuring the injected currents at different
clamped membrane potential, voltage-gated ion channels can be characterized.
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Figure 1. The gating of ion channels. Ion channels are gated by a variety of cellular
changes, such as the voltage gradient across the membrane, the binding of a ligand
(extracellular ligand or intracellular ligand), and a mechanical stress. The ion channels
can conduct electrical current by allowing ions to pass through in an open state.
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Figure 2. Diagram of the two- microelectrode voltage clamp (TEVC) on an oocyte.
The oocyte is placed under the dissecting microscope and gently injected with two
electrodes filled with conductive solution using micromanipulators. One electrode
monitors Vm, and the other is used to inject current to adjust Vm to the desired values.
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Chapter II MATERIALS AND METHODS
Plasmid construction
Plasmid pNCB1 (Figure 3), which contains a T7 promoter for in vitro cRNA
transcription, as well as the 5′ and 3′ untranslated regions of Xenopus β-globin gene for
protein expression in Xenopus laevis, was designed by Dr. H. Moriyama and synthesized
by GeneScript. The CM2 and DM2 gene products were synthesized and subcloned to
vector pNCB1, at the BamHI/XbaI and SmaI/XbaI location of the multiple cloning site of
pNCB1, respectively.
In vitro synthesis of mRNA
The mRNA transcripts that contain open reading frames coding for CM2 and DM2 were
synthesized in vitro with mMESSAGE mMACHINE Kit (Ambion). The recombinant
plasmids pNCB1–CM2 and pNCB1–DM2 were linearized downstream of the 3′UTR of
Xenopus β-globin gene with restriction enzyme PciI (NEB) and purified with
phenol/chloroform extraction and ethanol precipitation. The linearized plasmids were
used as templates for the synthesis of capped RNA (cRNA). The in vitro transcription
reaction was performed according to the instructions of mMESSAGE mMACHINE Kit
(Ambion) and incubated at 37°C for 2 h. Template DNA was removed with TURBO
DNase (supplied with kit), and the synthesized cRNA was recovered by phenol:
chloroform extraction and isopropanol precipitation. The purified cRNA was then
suspended in 20 µl nuclease-free H2O, followed with quantitation by gel electrophoresis.
Typically about 0.5 µg/µl RNA solution was obtained after purification.
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Injection of oocytes with mRNA
Defolliculated oocytes (Stage V and VI) were purchased from Xenopus 1 and stored in
MBSH solution (88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 15 mM HEPES, 0.3 mM
CaNO3, 0.33 mM CaCl2, 0.81 mM MgSO4, 10 µg/mL penicillin, and 10 µg/mL
streptomycin, pH 7.4). The oocytes with good contrast between the animal hemisphere
and vegetal hemisphere were selected using a dissecting microscope and stored on ice
prior to injection. The injection needle was obtained by pulling micropipettes
(Drummond L = 3.5 inches, OD = 1.14 mm, ID = 0.53 mm) with the Flamming/Brown
Micropipette Puller (Model P-97 Sutter Instrument). A 3–5 µm opening at the tip of the
injection needle was made with tweezers and sterile mineral oil was filled into the needle
with a 1 ml syringe. The needle was then filled with 2 µl cRNA sample solution through
a microinjector set on aspiration mode (Figure 4). The oocytes were microinjected in the
vegetal hemisphere with 50.6 nl cRNA at a speed of 23 µl/s. The injected oocytes were
transferred to a multi-well petri dish plate filled with MBSH solution and incubated at
16°C degree for 3–5 days. The oocyte incubation solution was changed every day after
injection.
Electrophysiological recordings
Two-electrode voltage clamp experiments were carried out to measure whole-cell oocyte
currents. Oocytes were placed in a recording chamber and were perfused with continuous
MBSH solution. The recording pipettes were obtained by pulling micropipettes (Sutter L
= 3.5 inches, OD = 1.0 mm, ID = 0.50 mm) with the Flamming/Brown Micropipette
Puller (Model P-97 Sutter Instrument) and filled with sterile 3 M KCl solution. For the
current electrode and voltage electrode pipettes, the tip was broken with fine forceps until
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a tip resistance of 1 MΩ was achieved. With the voltage potential set to −60.0 mV, the
oocytes were impaled separately with voltage and current electrodes. The impaled
oocytes were voltage clamped using the OC-725C-V oocyte clamp amplifier (Warner
Instruments) at a slow clamp mode (Figure 5). The clamped membrane potential was
observed as the voltage amplitude was adjusted from −80 mV to −160 mV in 10 s pulses.
The membrane potential was held at −60 mV, and the currents were low pass-filtered at 1
kHz. PL3508B75-V PowerLab system (ADInstruments) was used for the data recording
and signal processing. All electrophysiological recordings were carried out at room
temperature.
Isolation of plasma membrane complexes from Xenopus oocytes
Xenopus oocytes, 2–3 days post-injection, were used for the isolation of plasma
membrane fraction. Five oocytes were rinsed in MES-buffered saline solution (MBSS; 20
mM MES, 80 mM NaCl, pH 6.0) and incubated at room temperature for 10 min. The
following polymerization steps were performed at 4°C under mild agitation. The oocytes
were first rotated in MBSS solution with 1% colloidal silica for 30 min and rinsed
thoroughly in MBSS solution, followed by the rotation of oocytes in MBSS solution with
0.1% polyacrylic acid for 30 min and thoroughly washed in MBSS solution. The oocytes
were then homogenized in an Eppendorf tube with 1200 µl HbA (20 mM Tris, 5 MM
MgCl2, 5 MM NaH2PO4, 1 MM EDTA, 80 mM sucrose, 1 mM PMSF, 5 µg/ml leupeptin,
5 µg/ml peptatin, pH 7.4) and centrifuged for 30 s at 13.5 g. The top 1 ml supernatant
was removed after centrifugation and replaced with the same amount of fresh HbA. This
process was repeated four times and the supernatant were centrifuged at 13.5, 13.5, 24,
and 38 × g, respectively. A final centrifugation at max speed for 20 min was performed to
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pellet the purified plasma membranes, which were then resuspended with 10 µl HbA
buffer.
Mass spectrometry of purified plasma membrane complexes
Protein samples with purified plasma membrane complexes were sent to the Nebraska
Center for Mass Spectrometry (Lincoln, NE) for protein identification using tandem mass
spectrometry with a Waters Q-TOF Ultima mass spectrometer (Micromass/Waters,
Milford, MA). Extracted protein samples were sonicated 1 min at 0°C, reduced with 2
mM DTT at 37°C for 1 h, diluted with 50 MM ammonium bicarbonate, and digested with
10 ng/µl trypsin in situ. The samples were then concentrated with two 60 μl aliquots of
1:1 acetonitrile:water (v/v) containing 1% formic acid and subjected to a C18 reversed
phase column (75 μm × 15 cm; LC-Pacings, Dionex, Sunnyvale, CA). The acquired
MS/MS data were searched against the NCBI protein database with the significance
threshold set at P < 0.05.
Sequence alignment and transmembrane domain prediction
Protein sequences of M2 (GI 89033149), BM2 (GI 51340786), CM2 (GI 27531632),
and DM2 (685509396) were identified by searching against the NCBI (National Center
for Biotechnology Information) database and aligned using MAFFET 7.0 with default
settings (BLOSUM62 scoring matrix, gap opening penalty 1.53, offset value 0.0, leave
gappy regions). TMHMM Serer v.2.0 was used to predict the transmembrane helices in
proteins with default settings (Output format, Extensive, with graphics).
Molecular modeling
Swiss-Model was used to generate the molecular structure modeling of the
transmembrane domain of target protein DM2. The NMR structure of BM2 (PDB: 2KIX)
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was employed as the template and the sequence alignment between DM2 and BM2,
performed by ClustalW alignment, was also used as input for the modeling process.
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Figure 3. Plasmid pNCB1 construction. pNCB1 was derived from vector pGEM–HE
and vector pUC57. It contains the 5′ and 3′ UTR from Xenopus β-globin gene, which
are involved in the regulation of protein translation in oocytes, and T7 promoter that can
be recognized by T7 polymerase during cRNA transcription. DNA of interest can be
subcloned into MCS, which includes the SmaI, BamHI, EcoRV, XbaI, and PstI
restriction cutting sites. Restriction enzymes PciI, BsaXI, BpQI, SapI, and AffIII can be
used for plasmid linearization.
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Figure 4. Apparatus for cytoplasmic injection of Xenopus oocytes. The oocytes were
placed on a 35-mm tissue culture dish on the stage of a dissecting microscope. The
injection needle, pulled with micropipette puller, was filled with approximately 2 µl RNA
solution and was positioned over individual oocytes using a micromanipulator.

22

Figure 5. Apparatus for the measurement of the whole-cell currents of Xenopus
oocytes using the two-electrode voltage clamp method. The voltage electrode and
current electrode were placed on a micromanipulator and positioned over an oocyte,
which was placed in a perfusion chamber. Both electrodes were connected to a feedback
amplifier.
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Chapter III DETECTION AND CHARACTERIZATION OF THE ION
CHANNEL ACTIVITY OF DM2 IN XENOPUS LAEVIS OOCYTES
Study design

To characterize the ion channel activity of DM2 protein, we employed the Xenopus laevis
oocyte expression system combined with the electrophysiological recording system to
conduct the study. Capped mRNAs of the DM2-ORF (open reading frame) were injected
to the defolliculated Xenopus oocytes of stage V and VI, which were further incubated in
MBSH solution for around 3 days. After the DM2 protein was expressed in the oocytes,
two-electrode voltage clamp method was used to do the electrophysiological recording.
In vitro cRNA synthesis
The pNCB1–CM2 and pNCB1–DM2 plasmids were linearized with restriction enzyme
PciI (Figure 6) and used as the template for the in vitro capped mRNA synthesis of CM2
and DM2. The synthesized cRNA samples of CM2 and DM2 were purified and examined
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by gel electrophoresis (Figure 7). Both CM2-ORF and DM2-ORF transcripts were singlestranded RNAs and around 550 base pairs.
Expression of CM2 and DM2 in oocytes
To confirm that CM2 and DM2 protein are synthesized in oocytes of Xenopus laevis that
were injected with CM2-ORF and DM2-ORF transcripts, the plasma membrane proteins
of oocytes were extracted and examined by mass spectrometry.
Detection and characterization of the ion channel activity DM2
To determine whether DM2 has ion channel activity, Xenopus oocytes injected with CM2
mRNA, DM2 mRNA, and plasmid pNCB1 DNA were incubated in MBSH solution for
3–5 days and used for the measurement of whole cell currents by two-electrode voltage
clamp method. The membrane potential was held at −60 mV, and test pulses were
imposed from −80 to −160 mV in 10 mV increments (Figure 8). The currents that flowed
at the end of the hyperpolarizing pulse from −80 mV to −160 mV were recorded (Table
1). The whole cell currents of three oocytes for each sample were selected and plotted
against membrane voltages (Figure 9). For the uninjected oocytes and pNCB1 plasmid
DNA injected oocytes, the membrane currents induced upon hyperpolarization pulse
were extremely low, varying from −0.5 to −0.8 µA. As to the CM2 mRNA and DM2
mRNA injected oocytes, the membrane currents upon hyperpolarization from −80 mV to
−100 mV were relatively low, similar to those of the uninjected and pNCB1 vector DNA
injected oocytes. However, for the membrane currents upon hyperpolarization from −110
mV to −160 mV, we can clearly see that the values increased almost 4–5 times compared
with the currents induced from −80 mV to −100 mV. The curve of the current–voltage
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relationship for oocytes expressing DM2 almost overlaps with that of CM2, indicating
that DM2 has similar ion channel activity with CM2 protein.
Sequence alignment and motif prediction
The protein sequences of M2, BM2, CM2, and DM2 were aligned using MAFFET 7.0,
and the transmembrane (TM) domain prediction was accomplished with TMHMM Serer
v.2.0. According to the alignment and TM prediction results, HXXXW motif existed in
the transmembrane domains of M2 and BM2, consistent with previous studies. In
addition, corresponding to the HXXXW motif in M2 and BM2, an YXXXK motif was
identified in transmembrane domains of CM2 and DM2 (Figure 10). For CM2 protein,
tyrosine is located at position 67 and lysine is located position 71. As to DM2, tyrosine
amino acid was found in position 72 and lysine in position 76. The tyrosine amino acid in
YXXXK motif may play the role of tryptophan, which is responsible for the channel gate,
and the lysine amino acid could be the counterpart of histidine, conferring the ion
conductivity.
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Figure 6. Linearization of plasmids by PciI restriction enzyme. pNCB1–CM2 and
pNCB1–DM2 were digested with restriction enzyme PciI and purified phenol/chloroform
extraction and ethanol precipitation, followed by the gel electrophoresis analysis. DNA
ladder is indicated at the left of the gel (in bp).
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Figure 7. In vitro capped mRNA synthesis. The linearized plasmids pNCB1–CM2,
pNCB1–DM2 and control (pTRI–Xef1) were used as templates for the synthesis of
capped mRNA. The in vitro transcription reaction was performed with mMESSAGE
mMACHINE Kit (Ambion) kit. The synthesized CM2 and DM2 cRNA samples were
recovered and suspended with 20 µl nuclease-free H2O, followed with quantitation by gel
electrophoresis. DNA ladder (in bp) is indicated at the left of the gel.
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Table 1. The membrane currents of oocytes induced upon hyperpolarization.
Whole Cell Currents ((µA) evoked by voltage clamping
Clamping

Uninjected

pNCB1

CM2

DM2

voltage

DNA

mRNA

mRNA

(mV)

injected

injected

injected

-80

-0.51

-0.51

-0.51

-0.51

-90

-0.53

-0.54

-0.78

-0.56

-100

-0.53

-0.64

-1.02

-0.65

-110

-0.61

-0.67

-1.34

-0.97

-120

-0.62

-0.72

-1.64

-1.14

-130

-0.69

-0.81

-1.96

-1.36

-140

-0.71

-0.82

-2.07

-1.52

-150

-0.79

-0.96

-2.19

-1.85

-160

-0.83

-1.05

-2.51

-2.13
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Figure 8. Original recording file of membrane currents evoked by voltage
application over time. The holding potential was −60 mV, and test pulses were from
−80 to −160 mV in 10 mV increments during experiment.

31

Figure 9. The current–voltage relationship for oocytes in which the whole-cell
current were measured by the two-electrode voltage clamp method. The oocytes
injected with plasmid pNCB1 DNA, CM2 mRNA, DM2 mRNA as well as the uninjected
oocytes were incubated in MBSH solution for about 4 days before the measurement. The
holding potential was −60 mV, and test pulses were from −80 to −160 mV in 10 mV
increments during experiment.
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Figure 10. Sequence alignment of M2, BM2, CM2, and DM2 from influenza virus A,
B, C, and D. Amino acids colored as green are the transmembrane (TM) domains of M2
proteins. HXXXW motif found in M2 and BM2 is essential for channel function, with
histidine (red) conferring proton selectivity and tryptophan (blue) responsible for the
channel gate. YXXXK motif (yellow and purple) is found in CM2 and DM2,
corresponding to the HXXXW motif in M2 and BM2.
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Chapter IV DISCUSSION
Recently, the influenza virus D, a novel influenza virus found in swine and cattle, has
been characterized as a new genus in the Orthomyxoviridae family (Hause, 2014).
Though influenza virus D has been only isolated from swine and cattle, further studies
indicate that this pathogen has the potential to cause disease in humans and to threaten
human health (Collin, 2014). According to studies of influenza A, B, and C, M2, BM2,
and CM2, the ion channel proteins that play an important role in virus replication cycle,
are the ideal targets for the antiviral drugs (Clercq, 2006; Ohigashia, 2009). Therefore,
the counterpart of the ion channel proteins, DM2 of influenza D, is the potential ion
channel protein and may has important impact in the virus replication.
We expressed Influenza D DM2 protein in Xenopus laevis oocytes by injecting DM2
mRNA and measured the whole cell current via two-electrode voltage clamp method.
The data acquired showed that like M2 protein of influenza A, BM2 protein of influenza
B and CM2 protein of influenza C, DM2 exhibits ion channel activity. In addition, on the
basis of the characteristic that the current–voltage relationships of oocytes expressing
CM2 and oocytes expressing DM2 overlapped with each other, DM2 is likely to form a
voltage-gated ion channel, similar to CM2. The similarity of the ion channel activity
between CM2 and DM2 is consistent with their close phylogenetic relationship
(Lindstrom, 1999). Furthermore, the conclusion that CM2 and DM2 share similar ion
channel activity accords with our sequence alignment results, which indicated that the
YXXXK motif found in the transmembrane domains of CM2 and DM2 is responsible for
channel gating and ion selectivity. It is also supported by the structural model of DM2
(Figure 11), which showed that DM2 forms a left-handed coiled-coil tetramer where the
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residues Tyr 72 and Lys 76 pointing toward the pore. Tyr 72 is likely to control the
conformational change of the ion channel between opening state and closed state,
whereas Lys 76 confers the conductivity of ions. Moreover, the molecular clock analysis
of CM2 gene of influenza C viruses isolated in different years showed that the
substitution numbers and the year of isolation are not related. Besides, the substitution
rate is low, especially for the transmembrane domain, which is essential for the ion
channel activity. This can be explained by the importance of CM2 for the influenza C
replication cycle. The CM2 gene maintains low substitution rate to keep the ion channel
activity and ultimately keep its ability in uncoating and packaging during influenza C
replication.
On the other hand, M2 of influenza A and BM2 of influenza B are pH-gated ion channel
proteins that acidify the virion interiors in the acidic environment. The HXXXW motif,
of which histidine confers the proton conductivity and tryptophan regulates the channel
gate, are present in the transmembrane helices of M2 and BM2. At the same time, M2
and BM2 are genetically homogenous and phylogenetically close. Therefore, the tyrosine
and lysine in YXXXK motif found in both CM2 and DM2 may play the corresponding
role as HXXXW motif in M2 and BM2, with tyrosine monitoring the gate and lysine
conferring the ion selectivity.
Our study provides preliminary evidence that DM2 conducts voltage-gated ion channel
activity. However, to further characterize the ion channel properties of DM2, we need to
identify the ion selectivity of DM2 by changing the solution in which oocytes expressing
DM2 are placed in the process of two-electrode voltage clamp experiment. Additionally,
the role of YXXXK motif found in CM2 and DM2 can be validated by creating the
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mutations in the transmembrane domains of CM2 and DM2. Moreover, the antiviral
drugs to influenza D can be developed by testing the impact of certain drugs, such as
amantadine and rimantadine, on the ion channel activity of DM2.
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Figure 11. Diagram of the DM2 transmembrane structure. The four-transmembrane
helix domains are shown as green-colored ribbons. The residues pointing to the center,
Tyrosine72 and Lysine76, are shown in yellow sticks. This figure was created with SwissModel.
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